
Heme iron polypeptide HIP, also known as heme iron, is iron bound to porphyrin in hemoglobin and myoglobin. This form of iron is highly biologically active in the body and can be directly absorbed by intestinal mucosal epithelial cells in the form of porphyrin iron. Therefore, its absorption rate is usually high and is generally not affected by inhibitory factors such as phytate or promoting factors such as VC. Heme iron is mainly found in animal red meat, liver and blood, and is the main form of iron in these foods.
Heme iron is a dark substance with specific chemical properties that enable it to remain stable in various environments and conditions.
The global Heme Iron Polypeptide market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The “Heme Iron Polypeptide Industry Forecast” looks at past sales and reviews total world Heme Iron Polypeptide sales in 2023, providing a comprehensive analysis by region and market sector of projected Heme Iron Polypeptide sales for 2024 through 2030. With Heme Iron Polypeptide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Heme Iron Polypeptide industry.
This Insight Report provides a comprehensive analysis of the global Heme Iron Polypeptide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Heme Iron Polypeptide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Heme Iron Polypeptide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Heme Iron Polypeptide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Heme Iron Polypeptide.
United States market for Heme Iron Polypeptide is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Heme Iron Polypeptide is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Heme Iron Polypeptide is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Heme Iron Polypeptide players cover Sonac Burgum B.V., ILS Inc., Oranz Speciality Products, Shaanxi Pioneer Biotech Co, Xi'an ZB Biotech Co., Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Heme Iron Polypeptide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Food Grade
Feed Grade
Industrial Grade
Segmentation by Application:
Food and Drink
Health Products
Feed
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sonac Burgum B.V.
ILS Inc.
Oranz Speciality Products
Shaanxi Pioneer Biotech Co
Xi'an ZB Biotech Co., Ltd
Jiangsu Caiwei Biotechnology Co., Ltd.
Shandong Pingju Biotechnology Co., Ltd.
Shenzhen Jinfuyuan Biotechnology Co., Ltd.
Wuhan Jiyesheng Chemical Co., Ltd.
Shaanxi Chenming Biotechnology Co., Ltd.
Guangzhou Huayu Biotechnology
Hubei Haijia Biotechnology Co., Ltd.
Hebei Hongtao Bioengineering Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Heme Iron Polypeptide market?
What factors are driving Heme Iron Polypeptide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Heme Iron Polypeptide market opportunities vary by end market size?
How does Heme Iron Polypeptide break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Heme Iron Polypeptide Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Heme Iron Polypeptide by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Heme Iron Polypeptide by Country/Region, 2019, 2023 & 2030
2.2 Heme Iron Polypeptide Segment by Type
2.2.1 Food Grade
2.2.2 Feed Grade
2.2.3 Industrial Grade
2.3 Heme Iron Polypeptide Sales by Type
2.3.1 Global Heme Iron Polypeptide Sales Market Share by Type (2019-2024)
2.3.2 Global Heme Iron Polypeptide Revenue and Market Share by Type (2019-2024)
2.3.3 Global Heme Iron Polypeptide Sale Price by Type (2019-2024)
2.4 Heme Iron Polypeptide Segment by Application
2.4.1 Food and Drink
2.4.2 Health Products
2.4.3 Feed
2.4.4 Others
2.5 Heme Iron Polypeptide Sales by Application
2.5.1 Global Heme Iron Polypeptide Sale Market Share by Application (2019-2024)
2.5.2 Global Heme Iron Polypeptide Revenue and Market Share by Application (2019-2024)
2.5.3 Global Heme Iron Polypeptide Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Heme Iron Polypeptide Breakdown Data by Company
3.1.1 Global Heme Iron Polypeptide Annual Sales by Company (2019-2024)
3.1.2 Global Heme Iron Polypeptide Sales Market Share by Company (2019-2024)
3.2 Global Heme Iron Polypeptide Annual Revenue by Company (2019-2024)
3.2.1 Global Heme Iron Polypeptide Revenue by Company (2019-2024)
3.2.2 Global Heme Iron Polypeptide Revenue Market Share by Company (2019-2024)
3.3 Global Heme Iron Polypeptide Sale Price by Company
3.4 Key Manufacturers Heme Iron Polypeptide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Heme Iron Polypeptide Product Location Distribution
3.4.2 Players Heme Iron Polypeptide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Heme Iron Polypeptide by Geographic Region
4.1 World Historic Heme Iron Polypeptide Market Size by Geographic Region (2019-2024)
4.1.1 Global Heme Iron Polypeptide Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Heme Iron Polypeptide Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Heme Iron Polypeptide Market Size by Country/Region (2019-2024)
4.2.1 Global Heme Iron Polypeptide Annual Sales by Country/Region (2019-2024)
4.2.2 Global Heme Iron Polypeptide Annual Revenue by Country/Region (2019-2024)
4.3 Americas Heme Iron Polypeptide Sales Growth
4.4 APAC Heme Iron Polypeptide Sales Growth
4.5 Europe Heme Iron Polypeptide Sales Growth
4.6 Middle East & Africa Heme Iron Polypeptide Sales Growth
5 Americas
5.1 Americas Heme Iron Polypeptide Sales by Country
5.1.1 Americas Heme Iron Polypeptide Sales by Country (2019-2024)
5.1.2 Americas Heme Iron Polypeptide Revenue by Country (2019-2024)
5.2 Americas Heme Iron Polypeptide Sales by Type (2019-2024)
5.3 Americas Heme Iron Polypeptide Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Heme Iron Polypeptide Sales by Region
6.1.1 APAC Heme Iron Polypeptide Sales by Region (2019-2024)
6.1.2 APAC Heme Iron Polypeptide Revenue by Region (2019-2024)
6.2 APAC Heme Iron Polypeptide Sales by Type (2019-2024)
6.3 APAC Heme Iron Polypeptide Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Heme Iron Polypeptide by Country
7.1.1 Europe Heme Iron Polypeptide Sales by Country (2019-2024)
7.1.2 Europe Heme Iron Polypeptide Revenue by Country (2019-2024)
7.2 Europe Heme Iron Polypeptide Sales by Type (2019-2024)
7.3 Europe Heme Iron Polypeptide Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Heme Iron Polypeptide by Country
8.1.1 Middle East & Africa Heme Iron Polypeptide Sales by Country (2019-2024)
8.1.2 Middle East & Africa Heme Iron Polypeptide Revenue by Country (2019-2024)
8.2 Middle East & Africa Heme Iron Polypeptide Sales by Type (2019-2024)
8.3 Middle East & Africa Heme Iron Polypeptide Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Heme Iron Polypeptide
10.3 Manufacturing Process Analysis of Heme Iron Polypeptide
10.4 Industry Chain Structure of Heme Iron Polypeptide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Heme Iron Polypeptide Distributors
11.3 Heme Iron Polypeptide Customer
12 World Forecast Review for Heme Iron Polypeptide by Geographic Region
12.1 Global Heme Iron Polypeptide Market Size Forecast by Region
12.1.1 Global Heme Iron Polypeptide Forecast by Region (2025-2030)
12.1.2 Global Heme Iron Polypeptide Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Heme Iron Polypeptide Forecast by Type (2025-2030)
12.7 Global Heme Iron Polypeptide Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Sonac Burgum B.V.
13.1.1 Sonac Burgum B.V. Company Information
13.1.2 Sonac Burgum B.V. Heme Iron Polypeptide Product Portfolios and Specifications
13.1.3 Sonac Burgum B.V. Heme Iron Polypeptide Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sonac Burgum B.V. Main Business Overview
13.1.5 Sonac Burgum B.V. Latest Developments
13.2 ILS Inc.
13.2.1 ILS Inc. Company Information
13.2.2 ILS Inc. Heme Iron Polypeptide Product Portfolios and Specifications
13.2.3 ILS Inc. Heme Iron Polypeptide Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 ILS Inc. Main Business Overview
13.2.5 ILS Inc. Latest Developments
13.3 Oranz Speciality Products
13.3.1 Oranz Speciality Products Company Information
13.3.2 Oranz Speciality Products Heme Iron Polypeptide Product Portfolios and Specifications
13.3.3 Oranz Speciality Products Heme Iron Polypeptide Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Oranz Speciality Products Main Business Overview
13.3.5 Oranz Speciality Products Latest Developments
13.4 Shaanxi Pioneer Biotech Co
13.4.1 Shaanxi Pioneer Biotech Co Company Information
13.4.2 Shaanxi Pioneer Biotech Co Heme Iron Polypeptide Product Portfolios and Specifications
13.4.3 Shaanxi Pioneer Biotech Co Heme Iron Polypeptide Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Shaanxi Pioneer Biotech Co Main Business Overview
13.4.5 Shaanxi Pioneer Biotech Co Latest Developments
13.5 Xi'an ZB Biotech Co., Ltd
13.5.1 Xi'an ZB Biotech Co., Ltd Company Information
13.5.2 Xi'an ZB Biotech Co., Ltd Heme Iron Polypeptide Product Portfolios and Specifications
13.5.3 Xi'an ZB Biotech Co., Ltd Heme Iron Polypeptide Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Xi'an ZB Biotech Co., Ltd Main Business Overview
13.5.5 Xi'an ZB Biotech Co., Ltd Latest Developments
13.6 Jiangsu Caiwei Biotechnology Co., Ltd.
13.6.1 Jiangsu Caiwei Biotechnology Co., Ltd. Company Information
13.6.2 Jiangsu Caiwei Biotechnology Co., Ltd. Heme Iron Polypeptide Product Portfolios and Specifications
13.6.3 Jiangsu Caiwei Biotechnology Co., Ltd. Heme Iron Polypeptide Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Jiangsu Caiwei Biotechnology Co., Ltd. Main Business Overview
13.6.5 Jiangsu Caiwei Biotechnology Co., Ltd. Latest Developments
13.7 Shandong Pingju Biotechnology Co., Ltd.
13.7.1 Shandong Pingju Biotechnology Co., Ltd. Company Information
13.7.2 Shandong Pingju Biotechnology Co., Ltd. Heme Iron Polypeptide Product Portfolios and Specifications
13.7.3 Shandong Pingju Biotechnology Co., Ltd. Heme Iron Polypeptide Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Shandong Pingju Biotechnology Co., Ltd. Main Business Overview
13.7.5 Shandong Pingju Biotechnology Co., Ltd. Latest Developments
13.8 Shenzhen Jinfuyuan Biotechnology Co., Ltd.
13.8.1 Shenzhen Jinfuyuan Biotechnology Co., Ltd. Company Information
13.8.2 Shenzhen Jinfuyuan Biotechnology Co., Ltd. Heme Iron Polypeptide Product Portfolios and Specifications
13.8.3 Shenzhen Jinfuyuan Biotechnology Co., Ltd. Heme Iron Polypeptide Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Shenzhen Jinfuyuan Biotechnology Co., Ltd. Main Business Overview
13.8.5 Shenzhen Jinfuyuan Biotechnology Co., Ltd. Latest Developments
13.9 Wuhan Jiyesheng Chemical Co., Ltd.
13.9.1 Wuhan Jiyesheng Chemical Co., Ltd. Company Information
13.9.2 Wuhan Jiyesheng Chemical Co., Ltd. Heme Iron Polypeptide Product Portfolios and Specifications
13.9.3 Wuhan Jiyesheng Chemical Co., Ltd. Heme Iron Polypeptide Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Wuhan Jiyesheng Chemical Co., Ltd. Main Business Overview
13.9.5 Wuhan Jiyesheng Chemical Co., Ltd. Latest Developments
13.10 Shaanxi Chenming Biotechnology Co., Ltd.
13.10.1 Shaanxi Chenming Biotechnology Co., Ltd. Company Information
13.10.2 Shaanxi Chenming Biotechnology Co., Ltd. Heme Iron Polypeptide Product Portfolios and Specifications
13.10.3 Shaanxi Chenming Biotechnology Co., Ltd. Heme Iron Polypeptide Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Shaanxi Chenming Biotechnology Co., Ltd. Main Business Overview
13.10.5 Shaanxi Chenming Biotechnology Co., Ltd. Latest Developments
13.11 Guangzhou Huayu Biotechnology
13.11.1 Guangzhou Huayu Biotechnology Company Information
13.11.2 Guangzhou Huayu Biotechnology Heme Iron Polypeptide Product Portfolios and Specifications
13.11.3 Guangzhou Huayu Biotechnology Heme Iron Polypeptide Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Guangzhou Huayu Biotechnology Main Business Overview
13.11.5 Guangzhou Huayu Biotechnology Latest Developments
13.12 Hubei Haijia Biotechnology Co., Ltd.
13.12.1 Hubei Haijia Biotechnology Co., Ltd. Company Information
13.12.2 Hubei Haijia Biotechnology Co., Ltd. Heme Iron Polypeptide Product Portfolios and Specifications
13.12.3 Hubei Haijia Biotechnology Co., Ltd. Heme Iron Polypeptide Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Hubei Haijia Biotechnology Co., Ltd. Main Business Overview
13.12.5 Hubei Haijia Biotechnology Co., Ltd. Latest Developments
13.13 Hebei Hongtao Bioengineering Co., Ltd.
13.13.1 Hebei Hongtao Bioengineering Co., Ltd. Company Information
13.13.2 Hebei Hongtao Bioengineering Co., Ltd. Heme Iron Polypeptide Product Portfolios and Specifications
13.13.3 Hebei Hongtao Bioengineering Co., Ltd. Heme Iron Polypeptide Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Hebei Hongtao Bioengineering Co., Ltd. Main Business Overview
13.13.5 Hebei Hongtao Bioengineering Co., Ltd. Latest Developments
14 Research Findings and Conclusion
*If Applicable.
